These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Esophageal cancer still has a bad prognosis]. Seeliger HC; Voss AC Med Klin; 1980 Oct; 75(21):741-6. PubMed ID: 6779099 [No Abstract] [Full Text] [Related]
7. Outcome of esophageal carcinoma in the veteran affairs population: a comparative analysis from the Veteran Affairs Central Cancer Registry. Beg MS; Navaneethan U; Atiq M; Komrokji R; Safa M Am J Clin Oncol; 2009 Jun; 32(3):286-90. PubMed ID: 19433959 [TBL] [Abstract][Full Text] [Related]
8. Refluxtions on esophageal cancer: can we swallow the changes? Tepper J J Clin Oncol; 2000 Feb; 18(3):453-4. PubMed ID: 10653859 [No Abstract] [Full Text] [Related]
9. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis. Chang DT; Chapman C; Shen J; Su Z; Koong AC Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029 [TBL] [Abstract][Full Text] [Related]
10. Genetic variations in esophageal cancer risk and prognosis. Cheung WY; Liu G Gastroenterol Clin North Am; 2009 Mar; 38(1):75-91, viii. PubMed ID: 19327568 [TBL] [Abstract][Full Text] [Related]
11. Placement of Polyflex stents in patients with locally advanced esophageal cancer is safe and improves dysphagia during neoadjuvant therapy. Adler DG; Fang J; Wong R; Wills J; Hilden K Gastrointest Endosc; 2009 Oct; 70(4):614-9. PubMed ID: 19539918 [TBL] [Abstract][Full Text] [Related]
12. Therapy of localized esophageal cancer: it is time to reengineer our investigative strategies. Ajani J Onkologie; 2008 Jul; 31(7):360-1. PubMed ID: 18596381 [No Abstract] [Full Text] [Related]
13. [The neoadjuvant treatment of gastrointestinal tumors: time for rethinking?]. Ebert MP; Schmid RM Dtsch Med Wochenschr; 2009 Sep; 134(37):1835-7. PubMed ID: 19728255 [No Abstract] [Full Text] [Related]
14. Distal Esophageal Adenocarcinoma and Gastric Adenocarcinoma: Time for a Shared Research Agenda. Jansen M; Wright NA Adv Exp Med Biol; 2016; 908():1-8. PubMed ID: 27573764 [TBL] [Abstract][Full Text] [Related]
15. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Dumot JA; Vargo JJ; Falk GW; Frey L; Lopez R; Rice TW Gastrointest Endosc; 2009 Oct; 70(4):635-44. PubMed ID: 19559428 [TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance of the Mandard TRG classification after induction therapy in carcinoma of the oesophagus and cardia]. Zanoni A; Verlatoa G; Minicozzi A; Tomezzoli A; Giacopuzzi S; Di Cosmo M; Franceschetti I; Saladino E; De Manzoni G Chir Ital; 2009; 61(4):419-25. PubMed ID: 19845263 [TBL] [Abstract][Full Text] [Related]
17. [Prognostic and predictive factors of oesophageal carcinoma]. Blanchard P; Quero L; Hennequin C Bull Cancer; 2009 Apr; 96(4):379-89. PubMed ID: 19357013 [TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of survivin RNA expression in blood as a non-invasive predictor of response to neoadjuvant radiochemotherapy in esophageal cancer. Grimminger P; Vallböhmer D; Hoffmann A; Schulte C; Bollschweiler E; Schneider PM; Hölscher AH; Metzger R; Brabender J J Surg Oncol; 2009 Nov; 100(6):447-51. PubMed ID: 19653263 [TBL] [Abstract][Full Text] [Related]
19. Subset of esophageal adenocarcinoma expresses adhesion molecule l1 in contrast to squamous cell carcinoma. Rawnaq T; Kleinhans H; Uto M; Schurr PG; Reichelt U; Cataldegirmen G; Gawad KA; Yekebas EF; Schachner M; Izbicki JR; Kaifi JT Anticancer Res; 2009 Apr; 29(4):1195-9. PubMed ID: 19414364 [TBL] [Abstract][Full Text] [Related]
20. Transition in biology and philosophy in the treatment of gastroesophageal junction adenocarcinoma. Tepper JE; O'Neil B J Clin Oncol; 2009 Feb; 27(6):836-7. PubMed ID: 19139425 [No Abstract] [Full Text] [Related] [Next] [New Search]